Why the study?
Cardiovascular disease is the major cause of mortality and morbidity in peritoneal dialysis patients, and the clinical and prognostic value of plasma adiponectin level and adipose tissue mRNA expression in new patients was undetermined.
Does plasma adiponectin level or its adipose tissue mRNA expression predict body composition or survival in incident peritoneal dialysis patients?
Does plasma adiponectin level or its adipose tissue mRNA expression predict body composition or survival in incident peritoneal dialysis patients?
Plasma adiponectin levels correlate with adiposity but do not independently predict survival in incident peritoneal dialysis patients.
Adiponectin may aid prognostication in new PD patients; leaves open clinical utility pending validation.
Rationale & Objective Cardiovascular disease is the major cause of mortality and morbidity in peritoneal dialysis (PD) patients. Adiponectin, a key adipokine, is related to obesity and insulin resistance. We determined the clinical and prognostic value of plasma adiponectin level and its adipose tissue messenger RNA (mRNA) expression in new PD patients. Study Design Retrospective analysis of a prospective observational study. Setting & Participants 152 new PD patients from a single center; 6 adults undergoing abdominal surgeries without kidney disease served as controls. Predictors Plasma adiponectin level and its adipose tissue mRNA expression. Outcomes Body build and composition, patient and technique survival. Analytical Approach Adiponectin level and mRNA expression were grouped in quartiles for correlation analysis for body build and Cox regression for survival analysis. Results The median plasma adiponectin level was 31.98μg/mL (IQR, 16.81-49.49μg/mL), and adiponectin mRNA expression in adipose tissue was 1.65 times higher than in controls (IQR, 0.98-2.63). There was a modest but statistically significant correlation between plasma adiponectin and its adipose tissue mRNA expression ( r = 0.40, P <0.001). Plasma adiponectin level inversely correlated with body mass index, waist-hip ratio, mid-arm circumference, adipose tissue mass, plasma triglyceride ( r =-0.39, -0.38, -0.41, -0.38, and -0.30, respectively; P <0.001 for all), as well as serum insulin level ( r =-0.24, P =0.005). Similar correlations were present but less marked with adipose tissue adiponectin mRNA level. Neither plasma adiponectin level nor adipose tissue adiponectin mRNA level predicted patient or technique survival. Limitations Observational study, single center, single baseline measurement. Conclusions Plasma adiponectin level correlated with the degree of adiposity in new PD patients. However, neither plasma adiponectin level nor its adipose tissue mRNA expression was an independent prognostic indicator in kidney failure patients newly started on PD.
No takes yet. Share an insight, caveat, or question.
Than et al. (2022) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: